A potential $500 million project could reshape the university’s role in nuclear research and workforce training.
NEWTOWN, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical thre ...
As Southeast Asia continues to strengthen its role in the global semiconductor supply chain, Malaysia is increasingly drawing ...